Mortality prediction of retinal vessel diameters and function in a long-term follow-up of haemodialysis patients. Issue 16 (16th May 2022)
- Record Type:
- Journal Article
- Title:
- Mortality prediction of retinal vessel diameters and function in a long-term follow-up of haemodialysis patients. Issue 16 (16th May 2022)
- Main Title:
- Mortality prediction of retinal vessel diameters and function in a long-term follow-up of haemodialysis patients
- Authors:
- Günthner, Roman
Streese, Lukas
Angermann, Susanne
Lorenz, Georg
Braunisch, Matthias C
Matschkal, Julia
Hausinger, Renate
Stadler, David
Haller, Bernhard
Heemann, Uwe
Kotliar, Konstantin
Hanssen, Henner
Schmaderer, Christoph - Abstract:
- Abstract: Aim: Retinal vessel diameters are candidate biomarkers of mortality prediction in large population-based studies. We aimed to investigate the predictive value of retinal vessel diameters and flicker-induced retinal arteriolar and venular dilation on all-cause mortality in long-term follow-up of haemodialysis patients. Methods and results: Retinal vessel diameters as well as maximum arteriolar (aMax) and venular dilation (vMax) were investigated in 275 and 214 haemodialysis patients, respectively. Patients were observed in a long-term follow-up for a median period of 73 months. About 36% (76/214) and 41% (113/275) of patients died. Arteriolar and venular diameters were 175 ± 19 and 208 ± 20 µm, respectively. Median aMax and vMax were 1.6 (0.3–3.3) and 3.2 (2.0–5.1)%. Patients within the lowest tertile of vMax showed lower 5-year survival rates compared with the highest tertile (50.6 vs. 82.1%) and also exhibited a higher incidence of infection-related deaths (21.7 vs. 4.0%). Univariate hazard ratio (HR) per standard deviation increase of vMax for all-cause mortality was 0.69 (0.54–0.88) and was even more pronounced for infection-related mortality [HR 0.53 (0.33–0.83)]. Regarding all-cause mortality, multivariate adjustment for eight non-retinal mortality predictors including interleukin-6 did not attenuate the HR relevantly [0.73 (0.54–0.98)]. Arteriolar and venular diameters did not predict all-cause nor cardiovascular and infection-related mortality. Conclusions:Abstract: Aim: Retinal vessel diameters are candidate biomarkers of mortality prediction in large population-based studies. We aimed to investigate the predictive value of retinal vessel diameters and flicker-induced retinal arteriolar and venular dilation on all-cause mortality in long-term follow-up of haemodialysis patients. Methods and results: Retinal vessel diameters as well as maximum arteriolar (aMax) and venular dilation (vMax) were investigated in 275 and 214 haemodialysis patients, respectively. Patients were observed in a long-term follow-up for a median period of 73 months. About 36% (76/214) and 41% (113/275) of patients died. Arteriolar and venular diameters were 175 ± 19 and 208 ± 20 µm, respectively. Median aMax and vMax were 1.6 (0.3–3.3) and 3.2 (2.0–5.1)%. Patients within the lowest tertile of vMax showed lower 5-year survival rates compared with the highest tertile (50.6 vs. 82.1%) and also exhibited a higher incidence of infection-related deaths (21.7 vs. 4.0%). Univariate hazard ratio (HR) per standard deviation increase of vMax for all-cause mortality was 0.69 (0.54–0.88) and was even more pronounced for infection-related mortality [HR 0.53 (0.33–0.83)]. Regarding all-cause mortality, multivariate adjustment for eight non-retinal mortality predictors including interleukin-6 did not attenuate the HR relevantly [0.73 (0.54–0.98)]. Arteriolar and venular diameters did not predict all-cause nor cardiovascular and infection-related mortality. Conclusions: Long-term follow-up of patients on haemodialysis demonstrated the potential of retinal venular dilation capacity for mortality prediction, which was most pronounced for infection-related mortality. In the same cohort, retinal arteriolar and venular diameters showed no predictive value for hard endpoints. Retinal venular dilation but not arteriolar and venular diameters is a valuable diagnostic biomarker for risk prediction in patients with end-stage renal disease and should be considered for monitoring of critically ill patients. Graphical Abstract: Graphical Abstract … (more)
- Is Part Of:
- Cardiovascular research. Volume 118:Issue 16(2022)
- Journal:
- Cardiovascular research
- Issue:
- Volume 118:Issue 16(2022)
- Issue Display:
- Volume 118, Issue 16 (2022)
- Year:
- 2022
- Volume:
- 118
- Issue:
- 16
- Issue Sort Value:
- 2022-0118-0016-0000
- Page Start:
- 3239
- Page End:
- 3249
- Publication Date:
- 2022-05-16
- Subjects:
- Microcirculation -- Retinal vessels -- Mortality -- Haemodialysis -- Risk prediction
Cardiovascular system -- Diseases -- Periodicals
Cardiovascular system -- Periodicals
616.1 - Journal URLs:
- http://cardiovascres.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗
http://www.sciencedirect.com/science/journal/00086363 ↗ - DOI:
- 10.1093/cvr/cvac073 ↗
- Languages:
- English
- ISSNs:
- 0008-6363
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3051.490000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25320.xml